Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serostim Maintenance in HIV-associated Adipose Redistribution Syndrome
NCT00294918Phase 3Completed
- Sponsor
- EMD Serono
- Start
- Sep 2001
- Primary completion
- Feb 2003
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
01
Overview
Phase 3, randomised, open-label trial of somatropin in HIV-associated adipose redistribution syndrome (HARS) (3 arms), sponsored by EMD Serono. Primary endpoint: Percent change in trunk fat at Week 36. Started Sep 2001; status: completed.
02
Drugs
somatropin
03
Conditions
HIV-associated adipose redistribution syndrome (HARS)
Beyond the preview
Go deeper on NCT00294918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00294918.